Chul Kim

3.8k total citations · 1 hit paper
135 papers, 2.4k citations indexed

About

Chul Kim is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Chul Kim has authored 135 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Oncology, 56 papers in Pulmonary and Respiratory Medicine and 27 papers in Molecular Biology. Recurrent topics in Chul Kim's work include Lung Cancer Treatments and Mutations (40 papers), Lung Cancer Research Studies (21 papers) and Cancer Immunotherapy and Biomarkers (17 papers). Chul Kim is often cited by papers focused on Lung Cancer Treatments and Mutations (40 papers), Lung Cancer Research Studies (21 papers) and Cancer Immunotherapy and Biomarkers (17 papers). Chul Kim collaborates with scholars based in United States, South Korea and Japan. Chul Kim's co-authors include Michael Cook, Stephen V. Liu, Giuseppe Giaccone, Vinay Prasad, Arun Rajan, Deepa S. Subramaniam, Dae Hyun Kim, Udayan Guha, Eric L. Ding and Mary K. Townsend and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Chul Kim

125 papers receiving 2.4k citations

Hit Papers

Pembrolizumab in patients with thymic carcinoma: a single... 2018 2026 2020 2023 2018 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study
    2018 277 citations Giuseppe Giaccone, Chul Kim et al. profile →

Peers

Chul Kim
Cornelius F. Waller Germany
Tetsuzo Tagawa Japan
Hans Brunnström Sweden
Atsushi Kawaguchi Japan
Frances McSherry United States
Bhupendra Rawal United States
Francesco Facciolo Italy
Catharina M. Korse Netherlands
Lixin Zhou China
Anjali Gupta United States
Cornelius F. Waller Germany
Chul Kim
Citations per year, relative to Chul Kim Chul Kim (= 1×) peers Cornelius F. Waller

Countries citing papers authored by Chul Kim

Since Specialization
Citations

This map shows the geographic impact of Chul Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chul Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chul Kim more than expected).

Fields of papers citing papers by Chul Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chul Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chul Kim. The network helps show where Chul Kim may publish in the future.

Co-authorship network of co-authors of Chul Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Chul Kim. A scholar is included among the top collaborators of Chul Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chul Kim. Chul Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Choucair, Khalil, Andrew Elliott, Matthew J. Oberley, et al.. (2025). Molecular and immune landscape of tumours in geriatric patients with non-small cell lung cancer, melanoma and renal cell carcinoma. PubMed. 4(1). e000551–e000551.
2.
Luo, Jia, Mark G. Evans, Tolulope Adeyelu, et al.. (2024). Multiomic Characterization and Molecular Profiling of Nuclear Protein in Testis Carcinoma. JCO Precision Oncology. 8(8). e2400334–e2400334. 2 indexed citations
3.
Lim, Sun Min, et al.. (2024). P3.12D.02 Phase 1/2 Clinical Trial of JIN-A02, a 4th Generation EGFR-TKI in EGFR Mutated Advanced/metastatic Non-Small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology. 19(10). S346–S346. 1 indexed citations
4.
Iams, Wade T., Sharon Phillips, Adrian G. Sacher, et al.. (2023). A Multicenter Retrospective Chart Review of Clinical Outcomes Among Patients With KRAS G12C Mutant Non–Small Cell Lung Cancer. Clinical Lung Cancer. 24(3). 228–234. 2 indexed citations
5.
Nagasaka, Misako, Yasmine Baca, Joanne Xiu, et al.. (2023). Pan-tumor survey of RET fusions as detected by next-generation RNA sequencing identified RET fusion positive colorectal carcinoma as a unique molecular subset. Translational Oncology. 36. 101744–101744. 13 indexed citations
6.
Nagasaka, Misako, Mohammed Najeeb Al Hallak, Chul Kim, et al.. (2023). Multi-omic characterization of RCC1 expression and its association with molecular alterations, immune phenotypes, and cancer outcomes.. Journal of Clinical Oncology. 41(16_suppl). 3128–3128. 1 indexed citations
7.
Collins, Brian T., Eric Anderson, Marc Margolis, et al.. (2022). High-Risk Non-Small Cell Lung Cancer Treated With Active Scanning Proton Beam Radiation Therapy and Immunotherapy. Advances in Radiation Oncology. 8(2). 101125–101125. 4 indexed citations
8.
Yeung, Vincent, Chul Kim, Lesli A. Kiedrowski, Stephen V. Liu, & Joshua E. Reuss. (2022). Use of on-therapy ctDNA monitoring in a patient with KIF5B-RET fusion positive advanced non-small cell lung cancer: a case report. Translational Lung Cancer Research. 11(1). 111–116. 4 indexed citations
9.
Margolis, Marc, L. D. Campbell, Chul Kim, et al.. (2021). Thymic malignancies treated with active scanning proton beam radiation and Monte Carlo planning: early clinical experience. Acta Oncologica. 60(5). 649–652. 2 indexed citations
10.
Nagasaka, Misako, Vijendra K. Singh, Yasmine Baca, et al.. (2021). The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung Cancer. Clinical Lung Cancer. 23(1). 52–59. 21 indexed citations
11.
Lischalk, Jonathan W., et al.. (2020). Abscopal effect in pulmonary carcinoid tumor following ablative stereotactic body radiation therapy: a case report. Journal of Medical Case Reports. 14(1). 177–177. 6 indexed citations
12.
Kim, Chul, et al.. (2020). Immune checkpoint inhibitor use and tuberculosis: a systematic review of the literature. European Journal of Cancer. 132. 168–175. 38 indexed citations
13.
Kim, Chul, et al.. (2019). Role of Anti-EGFR Targeted Therapies in Stage III Locally Advanced Non-small Cell Lung Cancer: Give or Not to Give?. Current Oncology Reports. 21(9). 84–84. 13 indexed citations
14.
Kim, Chang‐Seok, Sangkyun Kim, Young‐Eun Kim, et al.. (2012). A Literature Review of the East-West Medical Combined Treatment. 18(2). 101–116. 4 indexed citations
15.
Kim, Chul, et al.. (2012). Pentoxifylline Reduces Tumor Necrosis Factor-α and HIV-Induced Vascular Endothelial Activation. AIDS Research and Human Retroviruses. 28(10). 1207–1215. 15 indexed citations
16.
Ahn, Jaeki, Chul Kim, & Yong Bum Park. (2010). Sonographic Appearance and Variations of Plantar Fibromatosis in the Korean. Annals of Rehabilitation Medicine. 34(5). 565–569. 1 indexed citations
17.
Kim, Tae Hyong, et al.. (2009). A Case of Lactic Acidosis Associated with Prolonged Linezolid Therapy. Kidney Research and Clinical Practice. 28(1). 41–43. 1 indexed citations
18.
Kim, Chul, Joohyuk Sohn, Joo Hang Kim, et al.. (2002). Phase II Study of Topotecan and Etoposide as Second-line Treatment in Chemotherapy-refractory Small-cell Lung Cancer. Cancer Research and Treatment. 34(5). 334–338. 2 indexed citations
19.
Park, Jun Yong, Chul Kim, Joohyuk Sohn, et al.. (2002). A Phase II Study of Gemcitabine Monotherapy in Breast Cancer Patients Refractory to Anthracycline and Taxane. Cancer Research and Treatment. 34(4). 274–279. 4 indexed citations
20.
Kim, Chul, et al.. (2002). The Change of Visual Evoked Potential in Patients with Myopia in Correction of Refraction. Annals of Rehabilitation Medicine. 26(6). 734–738.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cornelius F. Waller Breakdown of academic impact, for papers by Tetsuzo Tagawa Breakdown of academic impact, for papers by Hans Brunnström Breakdown of academic impact, for papers by Atsushi Kawaguchi Breakdown of academic impact, for papers by Frances McSherry Breakdown of academic impact, for papers by Bhupendra Rawal Breakdown of academic impact, for papers by Francesco Facciolo Breakdown of academic impact, for papers by Catharina M. Korse Breakdown of academic impact, for papers by Lixin Zhou Breakdown of academic impact, for papers by Anjali Gupta
Rankless by CCL
2026